2085.2000 -23.20 (-1.10%)
NSE Sep 19, 2025 15:42 PM
Volume: 686.6K
 

2085.20
-1.10%
Dolat Capital
Beyond gZetia . Budding niche product pipeline Ex US overall revenue growth was at 16% YoY and is expected to grow over 15% YoY going forward. The management has guided for better gross...
Glenmark Pharmaceuticals Ltd. has gained 43.18% in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended